Investing

Top Day Trader Alerts (C, RPRX, AAI, AVNR, AA, LINE, VICL)

These are this Wednesday morning’s top day trader and active trader stocks with price and volume moves.  More detailed price and volume analysis has been provided with a link to each stock story over at VSInvestor.com:

Citigroup (NYSE: C) is lower by less than 1% on what seemed like decent news.

Repros Therapeutics Inc. (NASDAQ: RPRX) is up over 100% on huge volume.

AirTran Holdings Inc. (NYSE: AAI) is down over 12% on a secondary offering announcement.

AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) is up over 6% on a patent allowance to treat pseudobulbar affect, which the company says there are no treatments on the market yet.

Alcoa Inc. (NYSE: AA) was very active in stock options late yesterday ahead of today’s earnings report.  We’d look for a continuation of that today as traders take deleveraged bets after such a large run up in the stock.

Linn Energy LLC (NASDAQ: LINE) is getting hit on high pre-market and also after-hours yesterday after it reported it would sell 6 million units in a secondary offering.

Vical Incorporated (NASDAQ: VICL) is trading up on positive Phase II trial data against CMV disease.

You can join our open email distribution list which goes out several times per week for reminders of the top day trader alerts, analyst upgrades and downgrades, IPO’s, key secondary offerings, guru investor data on Buffett and others, mergers, and more.

Jon C. Ogg

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.